Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 8;14(2):91.
doi: 10.3390/bios14020091.

Dual-Mode Graphene Field-Effect Transistor Biosensor with Isothermal Nucleic Acid Amplification

Affiliations

Dual-Mode Graphene Field-Effect Transistor Biosensor with Isothermal Nucleic Acid Amplification

Hyo Eun Kim et al. Biosensors (Basel). .

Abstract

Despite a substantial increase in testing facilities during the pandemic, access remains a major obstacle, particularly in low-resource and remote areas. This constraint emphasizes the need for high-throughput potential point-of-care diagnostic tools in environments with limited resources. Loop-mediated isothermal amplification (LAMP) is a promising technique, but improvements in sensitivity are needed for accurate detection, especially in scenarios where the virus is present in low quantities. To achieve this objective, we present a highly sensitive detection approach of a dual-mode graphene-based field-effect transistor (G-FET) biosensor with LAMP. The G-FET biosensor, which has a transparent graphene microelectrode array on a glass substrate, detects LAMP products in less than 30 min using both observable color changes and Dirac point voltage measurements, even in samples with low viral concentrations. This dual-mode G-FET biosensor emerges as a potential alternative to conventional RT-PCR for severe acute respiratory syndrome-associated coronavirus (SARS-CoV)-2 detection or point-of-care testing, particularly in resource-constrained scenarios such as developing countries. Moreover, its capacity for colorimetric detection with the naked eye enhances its applicability in diverse settings.

Keywords: SARS-CoV-2; colorimetric detection; graphene field-effect transistor; loop-mediated isothermal amplification; multi-array.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Schematic diagram and functional concept of the graphene field-effect transistor (G-FET) biosensor. (a) Chemical vapor deposition-grown graphene transfer accomplished using copper (Cu) as a sacrificial layer and polydimethylsiloxane (PDMS) as a supportive layer. (b) Design of the multi-electrode array featuring a graphene channel connecting the drain/source contacts, gate, and PDMS chamber. (c) Dual-mode monitoring illustrating the detection of amplicons through loop-mediated isothermal amplification (LAMP) via pH changes.
Figure 2
Figure 2
Detailed analysis of the transferred graphene sheet. (a) Raman spectra of the graphene sheet transferred to the multi-electrode array. (b) Ultraviolet–visible spectroscopy transmittance before and after transferring a single-layer graphene film to the glass substrate. (c) Transfer curves for the five-electrode array graphene field-effect transistor, with 1× phosphate buffer solution within the polydimethylsiloxane chambers. (d) Atomic force micrograph of the transferred graphene sheet.
Figure 3
Figure 3
Loop-mediated isothermal amplification assay with ten-fold serially diluted templates ranging from 1.48 × 108 to 1.48 × 101 copies per reaction. Graphical representations of amplification plots, melting curves, and standard curves for the (a) E and (b) RdRP genes.
Figure 4
Figure 4
Dual-mode analysis of the loop-mediated isothermal amplification assay using the graphene field-effect transistor biosensor. (a) Colorimetric and (b) electrical analyses of the Envelope (E) and RNA-dependent RNA polymerase (RdRP) genes. (c) Dirac point voltage (ΔVDirac) values for the clinical samples. NTC = non-template control.

Similar articles

Cited by

References

    1. Zhao Y., Cui C., Zhang K., Liu J., Xu J., Nisenbaum E., Huang Y., Qin G., Chen B., Hoffer M., et al. COVID19: A systematic approach to early identification and healthcare worker protection. Front. Public Health. 2020;8:205. doi: 10.3389/fpubh.2020.00205. - DOI - PMC - PubMed
    1. Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents. 2020;55:105924. doi: 10.1016/j.ijantimicag.2020.105924. - DOI - PMC - PubMed
    1. Acter T., Uddin N., Das J., Akhter A., Choudhury T.R., Kim S. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Sci. Total Environ. 2020;730:138996. doi: 10.1016/j.scitotenv.2020.138996. - DOI - PMC - PubMed
    1. Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141–154. doi: 10.1038/s41579-020-00459-7. - DOI - PMC - PubMed
    1. Tindale L.C., Stockdale J.E., Coombe M., Garlock E.S., Lau W.Y.V., Saraswat M., Zhang L., Chen D., Wallinga J., Colijn C. Evidence for transmission of COVID-19 prior to symptom onset. eLife. 2020;9:e57149. doi: 10.7554/eLife.57149. - DOI - PMC - PubMed